ArticleViruses2023

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan.

Jun Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.